-
CTN Annual Scientific Meeting: October 21-23, 2024 – Poster submissions open!
The National Drug Abuse Treatment Clinical Trials Network (CTN) will hold its Annual Scientific Meeting celebrating the 25th Anniversary of the CTN on Monday-Wednesday, October 21-23, 2024. The meeting will be held at the Crystal Gateway Marriott in Arlington, Virginia. Registration and hotel information coming soon — on or before the week of July 29. Poster session information Sharing of the results, experiences, techniques, and observations from performing our trials is a critical and exciting part of the CTN experience. To that end, CTN members are encouraged to submit posters for display at the 2024 CTN Annual Scientific Meeting Poster Session celebrating the 25th Anniversary of the CTN to be held on Monday, October 21, 2024. Poster submissions should be relatable to the CTN either directly (i.e. reporting on CTN studies, data, etc.) or indirectly (i.e. information that informs potential future CTN projects). As in previous years, we will consider new posters as well as posters that were presented at meetings over the past year. Event: CTN Annual Scientific Meeting Poster SessionVenue: Crystal Gateway Marriott (Arlington, VA)Date: Monday, October 21, 2024Time: 4:30 – 6:30 p.m. ET (exact times subject to change) Guidelines: In-person poster presenters will be provided with information on local poster printing options or shipping items directly to the hotel. Virtual Poster Display We will also post electronic copies of the posters on the meeting website. This will allow those not available for the in-person poster session to share their work. Please indicate on the submission form whether you are submitting the poster for…
-
Primary Care SIG Webinar: Are We There Yet? 25 Years of Research on Treating OUD in Primary Care (July 22, 12pm ET)
Join the CTN Primary Care SIG on July 22, 2024 (12-1pm EST) for their next webinar, featuring David Fiellin, MD from Yale School of Medicine presenting “Are we there yet? 25 years of research on treating OUD in primary care.” Please join the webinar here (no registration required).Passcode: 201068 Interested in presenting at a future Primary Care SIG meeting? Email Joe LeMaster at jlemaster@kumc.edu or Sebastian Tong at setong@uw.edu Posted July 15, 2024
-
CTN Youth SIG Webinar, July 19, 2024, 11am ET
The CTN Youth SIG is pleased to invite you to an upcoming presentation with two invited speakers: Presenters: Jesse D. Hinckley, MD, PhD and Chris Hammond, MH, PhD Friday, July 19th, 2024 (11:00 a.m.–12:00 p.m. ET) Join Zoom Meeting:https://dartmouth.zoom.us/j/94616304667?pwd=MHhGUjBzcmVNUVVlV1IyT0hjR3YrUT09 Meeting ID: 946 1630 4667Passcode: 047757One tap mobile+16469313860,,94616304667#,,,,*047757# US+13017158592,,94616304667#,,,,*047757# US (Washington DC) Exploring the association of cannabis use with depression and suicidal behavior in youth Jesse D. Hinckley, MD, PhDDivision of Addiction Science, Treatment & Prevention, Department of Psychiatry, University of Colorado School of Medicine School of Medicine The co-occurrence MDD and cannabis use is associated with worse mental health and substance use outcomes. Data will be presented from a secondary analysis of the National Comorbidity Survey-Adolescent Supplement (N=10,123), a nationally representative study of youth aged 13-18 years, exploring the association of cannabis use with major depressive disorder and suicidal behavior. Findings from this study will be considered in context of the extant literature to further explore the association between cannabis use and depression and potential mechanisms whereby these comorbid problems may increase the risk of youth engaging in suicidal behavior. Dr. Jesse Hinckley is an assistant clinical professor in the Division of Addiction Research, Treatment & Prevention within the Department of Psychiatry. Dr. Hinckley currently splits his time as a child and adolescent psychiatrist at a teaching hospital in Idaho and his research efforts at the University of Colorado School of Medicine. Dr. Hinckley’s primary research interests include better understanding the development of substance use disorders in adolescents, the interaction between substance use…
-
NIDA HIV Seminar Series: Social & Political Determinants of HIV Among People Who Use Drugs (July 31, 1pm ET)
Join Dr. Ricky Bluthenthal, PhD, on July 31, 2024 (1-2pm ET) for the next NIDA HIV Seminar! Dr. Bluthenthal is a Distinguished Professor of Population and Public Health Sciences at the Keck School of Medicine at the University of Southern California. He conducts community-partnered research at the intersection of harm reduction and health disparities among people who use drugs. In this session, Dr. Bluthenthal will talk about social and political determinants of HIV among people who use drugs. Register for the seminar here!
-
Webinar: Opioid Clinical Decision Support in Primary Care: CTN-0095 (1.5 CME/CE; June 26, 2024)
Join the Western States Node of the CTN and the Northwest and Pacific Southwest ATTCs for their next joint webinar, coming June 26, 2024, 11am-12:30pm PT! In this session, Opioid Clinical Decision Support in Primary Care: CTN-0095, presenters Stephanie Hooker, PhD, MPH (HealthPartners Institute), and Rebecca Rossom, MD, MS (HealthPartners Institute and PI of the CTN NorthStar Node), will discuss the design and implementation of Opioid Wizard, a clinical decision support tool embedded in the EHR for primary care clinicians. The goal of the Opioid Wizard tool is to help clinicians identify, screen, diagnose and treat opioid use disorder (OUD). They will also discuss one of the supplements to CTN 0095, which tested a training to reduce stigma towards people with OUD among primary care clinicians. 1.5 CME / CE available! To learn more about the available credit types and accreditation, check out our flyer! Learning objectives: About the speakers: Dr. Stephanie Hooker is Research Investigator at HealthPartners Institute with a background in clinical health psychology and public health. Dr. Hooker’s research interests are in behavioral and psychosocial influences on health and disease. The long-term goal of her research program is to develop interventions for health behavior change and well-being that can be delivered in healthcare and community settings. Dr. Hooker completed her PhD and MPH degrees at the University of Colorado Denver. Prior to joining the Institute in 2019, she completed a postdoctoral fellowship in Primary Care Behavioral Health at the University of Minnesota Department of Family Medicine…
-
Artificial Intelligence in Medicine & Imaging (AIMI) Symposium 2024 (May 15, Free, @ Stanford and Online)
Machine learning and artificial intelligence are redefining the boundaries of medicine, unleashing potential like never before to ensure better health for all. Sponsored by the Stanford University Center for Artificial Intelligence in Medicine & Imagining (AIMI), the FREE AIMI Symposium serves as their flagship annual meeting, focusing on the pioneering developments and significant strides in AI that are shaping the future of healthcare. They will highlight cutting-edge research and methods, showcase current and emerging real-world clinical applications, and address critical issues related to fairness and societal impact. This symposium serves as a pivotal forum for researchers, clinicians, policymakers, and anyone passionate about the future of healthcare to confront existing challenges, bridge critical gaps, and champion evidence-based strategies that advance health outcomes. Join the Center for AIMI in shaping a collaborative future where AI in health leads with groundbreaking research, innovative application, and a commitment to advancing health for all. This event will be held both at Stanford and online on May 15, 2024. REGISTRATION IS FREE! Find more information on the #AIMI24 website.
-
AHSR 2024: Abstract Submission Deadline Extended to May 10!
AHSR is still accepting individual presentation and symposium abstracts for innovative and impactful research that moves the field of addiction forward. Abstracts must be submitted by the person who intends to present the study in the case of an individual presentation, and by the chair/moderator in the case of a symposium session. We anticipate that accepted abstracts will be published in a peer-reviewed journal. The deadline for all submissions is Friday, May 10, 2024, at 11:59 PM PT. The AHSR Early Career Investigator Award recognizes scholars with early achievements and exceptional promise for future contributions to addiction health services research. Continuing the tradition of recognizing and supporting the next generation of researchers, we will select up to six awardees to be recognized at the 2024 conference. Each awardee will receive a financial award to help offset conference travel and registration. Deadline to apply for the Early Career Investigator Award is Tuesday, May 21, 2024, at 11:59 PM PT. Find out more about the AHSR conference here!
-
Addiction Health Services Research (AHSR) Conference 2024: Oct. 16-18
The Addiction Health Services Research (AHSR) conference, held since 2005, brings together researchers, policymakers, and treatment providers to solve the problems of inequity, access, effectiveness, and implementation of addiction services. This conference has been hosted across the United States at leading institutions, including Weill Cornell Medicine, Brandeis University, the University of Utah School of Medicine, Brown University, and more. This year, the conference is hosted by the Center for Dissemination and Implementation (CDI), a Stanford University initiative, at the historic Palace Hotel in the beautiful and bustling city of San Francisco, near quintessential landmarks including the cable cars and Chinatown. The AHSR website is now live and registration is open!
-
CTN Quarterly Steering Committee Meeting, April 16 – Updated start time: 2:45pm ET
The next Clinical Trials Network (CTN) Quarterly Steering Committee Meeting will be held virtually on Tuesday, April 16, 2024, from 2:45 p.m.– 5:00 p.m. ET. Note: this is an updated start time! Join using this link | Download agenda If you would like to be added to the calendar invitation please email ctnsupport@leedmci.com. Also, while we will not convene in person this Spring, we are excited to announce our next in-person meeting will be held in the Fall of 2024 to coincide with the CTN 25th Anniversary. Please stay tuned for a formal announcement soon with the dates and location.
-
Northeast Node Webinar: Emergency Department Initiation of Alcohol Use Disorder Treatment (April 25, 2024, 12pm ET)
In this session, Javad S. Mashkuri, MD (Central Vermont Medical Center) will review protocols for emergent treatment of Alcohol Use Disorder (AUD) in the Emergency Department (ED), discuss linkage and coordination of AUD care from ED to outpatient settings, discuss the role of peer recovery/ED care management in care planning and transitions, and will utilize case studies to illustrate the Refocus on Alcohol Dependence (ROAD) experience. Connect to Zoom (meeting ID & link): 919 7631 6490Passcode: 870392April 25, 2024 | 12-1pm ET 1 AMA PRA Category 1 CME Credit available. About the presenter As an emergency department (ED) physician, Dr. Mashkuri has a special interest in low barrier access to care for people who use drugs. He has developed and implemented community treatment pathways involving ED based medication assisted treatment and facilitated linkage to follow up care. He works closely with peer recovery specialists embedded in the ED to address the needs of ED patients with substance use disorder. Dr. Mashkuri finds that peers can connect with patients in ways that ED physicians and nurses without lived experience cannot. Dr. Mashkuri served as Medical Director at the Central Vermont Medical Center Emergency Department from 2016-2021. He is a graduate of the State University of New York Downstate Medical Center College of Medicine in Brooklyn, New York and completed a residency in Emergency Medicine at Oregon Health Science University in Portland, Oregon. Dr. Mashkuri is the owner of Vermont Emergency Addiction Services, LLC. He consults on treatment pathway models for low barrier…